Join the club for FREE to access the whole archive and other member benefits.

Beate Wieseler

Head of IQWiG's Drug Assessment Department.

Degree in Biology (Universities of Bonn and Freiburg). 1989 - 1994: Research Associate at the Universities of Bonn, Freiburg, and Munich (LMU). 1993 - 1995: Scientific journalist. 1996 - 2005: Clinical research at "gmi” (Organization for Applied Mathematics and Informatics) and Kendle International Inc.: planning, analysis, and reporting of clinical trials. Preparation of submission dossiers. Development and conduct of workshops on topics related to clinical research and drug development. 1997 - 2005 Head of the European Medical Writing Department, Kendle International Inc. April 2005 - September 2011: Deputy Head of IQWiG's Drug Assessment Department.

Visit website: https://www.iqwig.de/en/about-us/institute-structure/departments/drug-assessment/head-of-department-bw.2981.html

See also: Institute Institute for Quality and Efficiency in Health Care (IQWiG) - German agency responsible for assessing the quality and efficiency of medical treatments

Details last updated 05-Dec-2019

Beate Wieseler News

New drugs lack proof of added benefit over existing drugs

New drugs lack proof of added benefit over existing drugs

Medical Xpress - 10-Jul-2019

Old drugs are just as good as those new drugs - pharmaceutical mafia in action